1,0
23 dic 2024
Ex dipendente, più di 5 anni
Minneapolis, MN
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Pay and benefits are decent.
Svantaggi
Massive job cuts in early December 2024. Managers were not even aware their direct reports were being eliminated. Worker bees were cut but middle managers who don’t know how to roll up their sleeves and get their hands dirty kept their jobs. It is clear they are cutting expenses to look financially appealing to investors. The plan is to sell off divisions and focus on making the Medical/Surgical division ripe for acquisition. The CEO and about half of the executive leadership team came from Medtronic so don’t be surprised when Medtronic acquires what’s left of Solventum in the next few years.